Share
a year ago
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
a year ago
FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease
a year ago
US regulators approve two gene therapies for sickle cell disease
a year ago
US approves CRISPR gene-editing to treat sickle cell disease
Tags: Sickle-Cell Disease, sickle cell disease, Casgevy, U.S., First Crispr Gene-Editing Drug, CRISPR gene-editing, US, treatment, regulators, FDA Approves World, gene therapies,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines